Finance

Lists
Why is 002589 down 2.21%?
Dive Deeper
002589:SHE
Realcan Pharmaceutical Group Co Ltd
CN¥2.66
-2.21%
(-0.060) 1D
Nov 17, 3:04:54 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002589...
Open
CN¥2.71
High
CN¥2.72
Low
CN¥2.65
Mkt. cap
4.09B
Avg. vol.
58.21M
Volume
33.69M
Dividend
0.08%
Quarterly dividend
CN¥0.00
Ex-dividend date
Jun 30, 2026
P/E ratio
302.96
52-wk high
CN¥4.69
52-wk low
CN¥2.38
EPS
CN¥0.01
Shares outstanding
1.50B
No. of employees
2K
Open
CN¥2.71
High
CN¥2.72
Low
CN¥2.65
Mkt. cap
4.09B
Avg. vol.
58.21M
Volume
33.69M
Dividend
0.08%
Quarterly dividend
CN¥0.00
Ex-dividend date
Jun 30, 2026
P/E ratio
302.96
52-wk high
CN¥4.69
52-wk low
CN¥2.38
EPS
CN¥0.01
Shares outstanding
1.50B
No. of employees
2K
News stories
From web sources and news partners
About Realcan Pharmaceutical Group Co Ltd
CEO-
Employees2.41K
FoundedSep 21, 2004
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websiterealcan.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.89B
1.71B
1.71B
1.73B
Cost of goods sold
1.74B
1.49B
1.54B
1.52B
Cost of revenue
1.74B
1.49B
1.54B
1.52B
Research and development expenses
4.40M
2.71M
3.48M
1.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
128.25M
144.14M
143.12M
179.27M
Operating expense
175.33M
155.66M
141.50M
190.13M
Total operating expenses
1.92B
1.64B
1.68B
1.71B
Operating income
-29.77M
62.58M
25.97M
16.37M
Other non operating income
-34.43M
-2.05M
22.05M
-25.19M
EBT including unusual items
-1.86M
16.32M
21.74M
997.36K
EBT excluding unusual items
-2.72M
16.16M
21.73M
-2.54M
Income tax expense
-18.76M
697.10K
7.03M
-3.70M
Effective tax rate
1,009.59%
4.27%
32.32%
-371.31%
Other operating expenses
8.46M
8.65M
8.20M
8.79M
Net income
3.93M
10.37M
763.09K
-1.87M
Net profit margin
0.21%
0.61%
0.04%
-0.11%
Earnings per share
-
-
-
-
Interest and investment income
83.49M
10.96M
14.56M
35.93M
Interest expense
-22.01M
-55.32M
-40.85M
-29.66M
Net interest expenses
61.48M
-44.36M
-26.29M
6.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.54M
99.89M
56.35M
53.68M
Gain or loss from assets sale
-1.82M
-
-188.56K
188.56K
Upcoming events
AI content may include mistakes. Learn more
Google apps